Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. MSFT
6. NAVN
7. DFTX
8. CNC
9. KFY
10. SPY

Go back to Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates

Moderna (MRNA) Tops Q4 EPS by 51c, Beats on Revenue

February 13, 2026 7:03 AM EST

Moderna (NASDAQ: MRNA) reported Q4 EPS of ($2.11), $0.51 better than the analyst estimate of ($2.62). Revenue for the quarter came in at $678 million versus the consensus estimate of $662.84 million.

For earnings history and earnings-related data on Moderna (MRNA) click here.

... More